000 01613 a2200445 4500
005 20250516223529.0
264 0 _c20150115
008 201501s 0 0 eng d
022 _a1475-6773
024 7 _a10.1111/1475-6773.12201
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aClark, Robin E
245 0 0 _aThe impact of prior authorization on buprenorphine dose, relapse rates, and cost for Massachusetts Medicaid beneficiaries with opioid dependence.
_h[electronic resource]
260 _bHealth services research
_cDec 2014
300 _a1964-79 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdult
650 0 4 _aAnalgesics, Opioid
_xadministration & dosage
650 0 4 _aBuprenorphine
_xadministration & dosage
650 0 4 _aCohort Studies
650 0 4 _aCosts and Cost Analysis
650 0 4 _aDrug and Narcotic Control
650 0 4 _aFemale
650 0 4 _aHealth Expenditures
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMassachusetts
650 0 4 _aMedicaid
_xeconomics
650 0 4 _aOpiate Substitution Treatment
_xeconomics
650 0 4 _aOpioid-Related Disorders
_xdrug therapy
650 0 4 _aRecurrence
650 0 4 _aUnited States
700 1 _aBaxter, Jeffrey D
700 1 _aBarton, Bruce A
700 1 _aAweh, Gideon
700 1 _aO'Connell, Elizabeth
700 1 _aFisher, William H
773 0 _tHealth services research
_gvol. 49
_gno. 6
_gp. 1964-79
856 4 0 _uhttps://doi.org/10.1111/1475-6773.12201
_zAvailable from publisher's website
999 _c24021812
_d24021812